GregoryLanzaMD

PubMed

• Loss of Consciousness in a 34 Yo Male Related to Marijuana.
  Azim Merchant, Aashray Singareddy, Leighton McCabe, Rachana Raghupathy, Qianli Wang
  Annals of Case Reports. 2023-01-01
• 2 citations
  Transferrin receptor in primary and metastatic breast cancer: Evaluation of expression and experimental modulation to improve molecular targeting.
  Francesca Fontana, Alison K Esser, Christopher Egbulefu, Partha Karmakar, Xinming Su
  Plos One. 2023-01-01
• 17 citations
  Implementation and prospective clinical validation of AI-based planning and shimming techniques in cardiac MRI.
  Masoud Edalati, Yuan Zheng, Mary P. Watkins, Junjie Chen, Liu Liu
  Medical Physics. 2021-11-08

Journal Articles

• Bicuspid pulmonic valve and pulmonary artery aneurysm  
  Jamis-Dow CA, Barbier GH, Watkins MP, Lanza GM, Caruthers SD, Wickline SA, Cardiol Res, 1/1/2014
• Seeing it through: Translational validation of new medical imaging modalities  
  Aldrich MB, Marshall MV, Sevick-Muraca EM, Lanza G, Kotyk J, Culver J, Wang LV, Uddin J, Crews BC, Marnett LJ, Liao JC, Contag C, Crawford JM, Wang K, Reisdorph B, App..., Biomed Opt Express, 1/1/2012
• Magnetic Nanoparticles for Early Detection of Cancer by Magnetic Resonance Imaging  
  Lin WB, Hyeon T, Lanza GM, Zhang M, Meade TJ, MRS Bulletin, 1/1/2009
• Perfluorocarbon nanoparticles for molecular imaging and targeted therapeutics  
  Hughes M, Caruthers S, Tran T, Marsh J, Wallace K, Cyrus T, Partlow K, Scott M, Lijowski M, Neubauer A, Winter P, Hu G, Zhang H, McCarthy J, Maurizi B, Allen J, Caradi..., Proceedings IEEE, 1/1/2008
• Noncavitational nonporative ultrasound elicits marked in vivo augmentation of tumor drug delivery with perfluorocarbon nanoparticles  
  Baldwin SL, Soman NR, Lanza GM, Wickline SA, Proceedings IEEE, 1/1/2008
• Ultrasonic molecular imaging of primordial angiogenic vessels in the papilloma virus transgenic mouse with AlphavBeta3-integrin targeted nanoparticles using Renyi entr...  
  Wallace KD, Marsh JN, Thomas LJ, Neumann RG, Arbeit JM, Lanza GM, Wickline SA, Proceedings IEEE International Ultrasonics Symp, 1/1/2008
• Real-time Renyi entropy processing for molecular imaging using targeted nanoparticles  
  Wallace K, McCarthy J, Wickerhauser V, Marsh J, Lanza G, Wickline S, Hughes M, J Acoust Soc Am, 1/1/2008
• Nanotechnology in the diagnosis of atherosclerotic disease  
  Erpelding TN, Caruthers SD, Wickline SA, Lanza GM, Expert Opin Med Diagn, 1/1/2008
• Spectral properties of a biofunctional PARACEST europium chelate: An intermediate for targeted imaging applications  
  Adair C, Woods M, Zhao P, Pasha A, Winter PM, Lanza GM, Athey P, Sherry AD, Kiefer GE, Contrast Media Mol Imaging, 1/1/2007
• Imaging of Vx-2 rabbit tumors with AlphavBeta3 integrin-targeted 111In nanoparticles  
  Hu G, Lijowski M, Zhang H, Partlow KC, Caruthers SD, Kiefer G, Gulyas G, Athey P, Scott MJ, Wickline SA, Lanza GM, Int J Cancer, 1/1/2007
• Properties of an entropy-based signal receiver with an application to ultrasonic molecular imaging  
  Hughes MS, McCarthy JE, Marsh JN, Arbeit JM, Neumann RG, Fuhrhop RW, Wallace KD, Znidersic DR, Maurizi BN, Baldwin SL, Lanza GM, Wickline SA, J Acous Soc Am, 1/1/2007
• Fibrin-targeted perfluorocarbon nanoparticles for targeted thrombolysis  
  Marsh JN, Senpan A, Hu G, Scott MJ, Gaffney PJ, Wickline SA, Lanza GM, Nanomedicine, 1/1/2007
• A fibrin-targeted multi-modality nanoparticle contrast agent for MRI and SPECT  
  Caruthers SD, Lijowski M, Hu G, Neubauer AM, Scott MJ, Fuhrhop RW, Gaffney PJ, Wickline SA, Lanza GM, J Cardiovasc Magn Reson, 1/1/2007
• Qualitative properties of an entropy-based signal detector  
  Hughes MS, Marsh JN, Wallace KD, Thomas LJ, Lanza GM, Wickline SA, McCarthy JE, Maurizi BN, Proceedings IEEE, 1/1/2007
• Clinical applications of perfluorocarbon nanoparticles for molecular imaging and targeted therapeutics  
  Tran TD, Caruthers SD, Hughes M, Cyrus T, Winter PM, Morawski AN, Wickline SA, Lanza GM, Int J Nanomedicine, 1/1/2007
• Ultrasound energy rapidly labels stem/progenitor cells with nanoparticle beacons without disrupting membrane integrity  
  Partlow KC, Brant JA, Marsh JN, Nolta JA, Hughes MS, Lanza GM, Wickline SA, Proc IEEE Ultrason Symp, 1/1/2007
• Targeted magnetic resonance imaging contrast agents  
  Caruthers SD, Winter PM, Wickline SA, Lanza GM, Methods Mol Med, 1/1/2006
• Nanotechnology for molecular imaging and targeted drug delivery  
  Wickline SA, Lanza GM, Annals of Oncology, 1/1/2006
• Characterization of digital waveforms using thermodynamic analogs: Detection of contrast-targeted tissue in vivo  
  Hughes MS, Marsh JN, Zhang H, Woodson AK, Allen JS, Lacy EK, Caradine C, Lanza GM, Wickline SA, IEEE Trans Ultrason Ferroelectr Freq Contr, 1/1/2006
• Differentiation of dystrophic and normal skeletal muscle tissues with energy and entropy images acquired in vivo from the biceps of MDX and wild-type mice  
  Wallace KD, Marsh JN, Baldwin SL, Connolly AM, Keeling R, Lanza GM, Wickline SA, Hughes MS, Proc IEEE Ultrason Symp, 1/1/2006
• Applications of nanotechnology to atherosclerosis, thrombosis, and vascular biology  
  Wickline SA, Neubauer AM, Winter P, Caruthers S, Lanza G, Arterioscler Thromb Vasc Biol, 1/1/2006
• In vitro demonstration using 19F magnetic resonance to augment molecular imaging with paramagnetic perfluorocarbon nanoparticles at 15T Tesla  
  Caruthers SD, Neubauer AM, Hockett FD, Lamerichs R, Winter PM, Scott MJ, Gaffney PJ, Wickline SA, Lanza GM, Invest Radiol, 1/1/2006
• Acoustic activation of targeted liquid perfluorocarbon nanoparticles does not compromise endothelial integrity  
  Soman NR, Marsh JN, Hughes MS, Lanza GM, Wickline SA, IEEE Trans Nanobioscience, 1/1/2006
• MR three-dimensional molecular imaging of intramural biomarkers with targeted nanoparticles  
  Cyrus T, Abendschein DR, Caruthers SD, Harris TD, Glattauer V, Werkmeister JA, Ramshaw JA, Wickline SA, Lanza GM, J Cardiovasc Magn Reson, 1/1/2006
• Nanomedicine opportunities for cardiovascular disease with perfluorocarbon nanoparticles  
  Lanza GM, Winter PM, Caruthers SD, Hughes MS, Cyrus T, Marsh JN, Neubauer AM, Partlow KC, Wickline SA, Nanomedicine, 1/1/2006
• Join now to see all

Books/Book Chapters

• Translational Research in Biophotonics: Four National Case Studies. 
  Chapter: Clinical translation of photoacoustic tomography, Chapter 5. 
  Page 83 - 157Erpelding TN, Maslov K, Appleton C, Margenthaler JA, Pashley MD, Zou J, Culver JP, Akers WK, Achilefu S, Pan D, Lanza GM, Wang LVEditors: RJ Nordstrom.SPIE Press, Bellingham, WA2014
• Drug Delivery Applications of Noninvasive Imaging: Validation from Biodistribution to Sites of Action 
  Chapter: Perfluorocarbon nanoparticles: Translating bench opportunities to the clinic. 
  Page 296 - 307Lanza GM, Winter PM, Caruthers SD, Schmieder AH, Wickline SAEditors: Chun Li and Me Tian.Wiley2013
• Nanotechnology in Modern Medical Imaging and Interventions 
  Chapter: Chapter 5. Perfluorocarbon Nanoparticles: A Theranostic Technology for MR Imaging 
  Page 87 - 118Lanza GM, Caruthers SD, Schmieder AH, Pan D, Hu G, Zhang H, Senpan A, Allen JS, Williams T, Scott MJ, Wickline SAEditors: Yang X.Nova Science Publishers2013
• Nanopharmaceutics: The potential application of nanomaterials Singapore 
  Chapter: Perfluorocarbon nanoparticles: A theranostic platform technology. 
  Page 293 - 345Lanza GM, Winter PM, Caruthers SD, Hughes MS, Hu G, Pan D, Schmieder AH, Pham C, Wickline SEditors: Liang XJ.World Scientific Publishing Co.2013
• Textbook of CMR 
  Chapter: Recent advances in contrast agents for magnetic resonance imaging. 
  Pan D, Lanza GMSchattauer-PublishersEdition 2nd,2012
• Bionanotechnology II: Global Prospects 
  Chapter: Theragnostic Nanoparticles with the Power to Diagnose, Treat, and Monitor Diseases. 
  Page 89 - 102Caruthers SD, Lanza GM, Wickline SEditors: Reisner D..CRC Press, Taylor & Francis Group2011
• Molecular Imaging: Principles and Practice 
  Chapter: Fluorocarbon Agents for Quantitative Multimodal Molecular Imaging and Targeted Therapeutics. 
  Wickline SA, Mason RP, Caruthers SD, Chen J, Winter PM. Hughes MS, Lanza GMEditors: Weissleder R, Ross BD, Rehemtulla A, Gambhir SS.McGraw-Hill2010
• Nanotechnology: Nanomedicine 
  Chapter: From in vivo ultrasound and MRI imaging to therapy: Contrast agents based on target-specific nanoparticles. 
  Page 19 - 50Wallace KD, Hughes, MS, Marsh JN, Caruthers SD, Lanza GM, Wickline SAEditors: V Vogel.Wiley-VCH, Weinheim, Germany2009
• Cardiovascular Molecular Imaging 
  Chapter: Atherosclerosis imaging with nanoparticles. 
  Page 215 - 224Lanza GM, Winter PM, Neubauer AM, Crowder KC, Caruthers SD, Wickline SAEditors: Gropler RJ, Glover DK, Sinusas AJ, Taegtmeyer H.Informa Healthcare, New York, NY2007
• Contemporary Cardiology: Cardiovascular magnetic resonance imaging 
  Chapter: Magnetic resonance molecular imaging and targeted therapeutics. 
  Page 639 - 662Neubauer AM, Winter P, Caruthers S, Lanza GM, Wickline SAEditors: Kwong RY.Humana Press Inc.2007
• The Vulnerable Plaque 
  Chapter: Targeted nanoparticle contrast agents for vascular molecular imaging and therapy. 
  Page 289 - 302Wickline SA, Neubauer AM, Winter P, Caruthers S, Lanza GEditors: R Waksman, PW Serruys, J Schaar.Informa Healthcare, Abindon, UKEdition 2nd,2007
• Diagnostic and therapeutic perfluorocarbon nanoparticles. 
  Page 365 - 380Winter PM, Caruthers SD, Lanza GM, Wickline SAWiley-VCH Verlag GmbH & Co. KGaA2007
• Nanomaterials for Cancer Therapy and Diagnosis (Series: Nanotechnologies for Life Sciences, Volume 6) 
  Chapter: Nanoparticles for magnetic resonance imaging of tumors. 
  Page 121 - 146Cyrus T, Winter PM, Caruthers SD, Wickline SA, Lanza GMEditors: Challa S.S.R. Kumar.Wiley-VCH Verlag GmbH2007
• ACS Symposium Series 
  Chapter: Molecular imaging and therapy: New paradigms for 21st century medicine In Polymeric Drug Delivery I: Particulate Drug Carriers. 
  Page 295 - 311Lanza GM, Winter PM, Hughes MS, Caruthers SD, Marsh JN, Morawski AM, Schmieder AH, Scott MJ, Fuhrhop RW, Zhang H, Hu G, Lacy EK, Allen JS, Wickline SA2006
• Advances in Healthcare Technology 
  Chapter: Targeted nanoparticles for molecular imaging and therapy: A multimodality approach to molecular medicine. 
  Page 305 - 322Caruthers SD, Wickline SA, Lanza GMEditors: G Spekowius, T Wendler.Springer, Dordrecht, The Netherlands2006
• "Nanofabrication Towards Biomedical Applications: Techniques, Tools, Applications and Impact." 
  Chapter: Nanotechnologies for cellular and molecular imaging by MRI. 
  Page 227 - 250Winter PM, Caruthers SD, Wickline SA, Lanza GMEditors: C Kumar, J Hormes, C Leuschner.Wiley-VCH, Weinheim, Germany2005
• "Cardiovascular Molecular Imaging” 
  Chapter: Atherosclerosis imaging with nanoparticles. 
  Lanza GM, Winter PM, Neubauer AM, Crowder KC, Caruthers SD, Wickline SASinusas and Groppler2005
• "Magnetic Resonance Imaging: Methods and Biologic Applications" 
  Chapter: Targeted Magnetic Resonance Imaging Contrast Agents 
  Page 387 - 400Caruthers SD, Winter PM, Wickline SA, Lanza GMEditors: PV Prasad.Humana Press Inc., Totowa, NJ2005
• Magnetic Resonance Imaging: Methods in Molecular Medicine 
  Chapter: Targeted MRI Contrast Agents. 
  Page 387 - 400Caruthers SD, Winter Pm, Wickline SA, Lanza GM2005
• Targeted contrast agents for magnetic resonance imaging and ultrasound. 
  Morawski AM, Lanza GM, Wickline SA2005
• Expert Review of Cardiovascular Therapy 
  Chapter: Nanoparticle formulations for cardiac magnetic resonance imaging. 
  Page 705 - 715Tillman C, Winter PW, Wickline SA, Lanza GM2005
• Current Topics in Developmental Biology, “In Vivo Cellular and Molecular Imaging" 
  Chapter: 1H/19F magnetic resonance molecular imaging with perfluorocarbon nanoparticles. 
  Lanza GM, Winter PM, Neubauer AM, Caruthers SD, Hockett F, Wickline SAEditors: Eric T. Ahrens.2005
• Nanofabrication Towards Biomedical Applications 
  Chapter: Nanotechnologies for cellular and molecular imaging by MRI: Techniques, Tools, Applications, and Impact. 
  Page 227 - 249Winter PM, Caruthers SD, Wickline SA, Lanza GMEditors: CSSR Kumar, J Hormes, C Leuschner.Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim, Germany2005
• Cardiovascular Magnetic Resonance: Established and Emerging Applications 
  Chapter: Molecular Imaging. 
  Page 501 - 516Lanza GM, Caruthers SD, Wickline SAEditors: A. Lardo, AZ Fayad, A.N. Chronos, V Fuster.Martin Dunitz, London2003
• Progress in Cardiovascular Diseases 
  Chapter: Targeted ultrasonic contrast agents for molecular imaging and therapy. 
  Page 13 - 31Lanza GM. Wickline SAEditors: M. Lesch and E H. Sonnenblick.W.B. Saunders, Philadelphia, PA2000
• Join now to see all

Abstracts/Posters

• Noninvasive diagnosis of ventricular assist device thrombosis using fibrin-specific nuclear imaging.
  Coi G, Akers W, Scott M, Allen J, Prasad SM, Silvestry SC, Tia Y-C, Achilefu SA, Ewald GA, Lanza GM, Circulation, 1/1/2013
• Regional expression of myocardial sheet dysfunction in dystrophin-deficient cardiomyopathy elucidated with diffusion tensor MRI and optical calcium imaging.
  Cheng YJ, Lang D, Caruthers SD, Lanza G, Efimov I, Chen J, Wickline SA, J Cardiovasc Magn Reson, 1/1/2012
• Thrombus-specific manganese-based “nanobialys” for MR molecular imaging of ruptured plaque.
  Pan D, Caruthers SD, Senpan A, Schmieder AH, Williams TA, Scott MJ, Gaffney PJ, Wickline SA, Lanza G, J Cardiovasc Magn Reson, 1/1/2012
• Copper nanocolloids: A new thrombus molecular imaging approach to ruptured plaque.
  Pan D, Caruthers SD, Senpan A, Scott MJ, Schmieder AH, Gaffney PJ, Wickline SA, Lanza G, J Cardiovasc Magn Reson, 1/1/2012
• PPACK and bivalirudin nanoparticles enable simultaneous imaging and potent inhibition of acute clotting.
  Myerson JW, Allen JS, Williams TA, He L, Tollefsen DM, Lanza G, Caruthers SD, Wickline SA, J Cardiovasc Magn Reson, 1/1/2012
• In vivo quantitative imaging of angiogenesis-targeted PFOB nanoparticles in a hypercholesterol rabbit model using 19F-MRI with ultra-short echo time balanced SSFP.
  Goette MJ, Schmieder AH, Williams TA, Allen JS, Keupp J, Lanza G, Wickline SA, Caruthers SD, J Cardiovasc Magn Reson, 1/1/2012
• Probing atherosclerotic angiogenesis with new manganese-based nanocolloid for T1-weighted MRI.
  Wang K, Pan D, Schmieder AH, Zhang H, Senpan A, Williams TA, Hu G, Caruthers SD, Wickline SA, Shen B, Lanza G, J Cardiovasc Magn Reson, 1/1/2012
• Evaluating endothelial damage in acute kidney injury with perfluorocarbon (PFC) nanoparticles (NP) and 19F MRI.
  Hu L, Chen J, Yang X, Caruthers SD, Lanza GM, Wickline SA, Proc Intl Soc Mag Reson Med, 1/1/2012
• The irons in your fire: Iron oxide particles & paramagnetic nanoparticles.
  Pan D, Senpan A, Schmieder A, Wickline S, Caruthers S, Lanza GM, Proc Intl Soc Mag Reson Med, 1/1/2012
• Thrombin-inhibiting perfluorocarbon nanoparticles manifest versatile inhibition and contrast for thrombosis.
  Myerson JW, He L, Allen SJ, Williams TA, Tollefsen DM, Lanza GM, Caruthers SD, Wickline SA, Proc Intl Soc Mag Reson Med, 1/1/2012
• Quantitative molecular imaging of fluorinated agents: 19F flip angle calibration using 1H power settings.
  Goette MJ, Lanza GM, Wickline SA, Caruthers SD, Proc Intl Soc Mag Reson Med, 1/1/2012
• A novel fluorine relaxation switch for tracking the binding and intracellular processing of molecularly targeted nanoparticle contrast agents.
  Hu L, Chen J, Caruthers SD, Lanza GM, Wickline SA, Proc Intl Soc Mag Reson Med, 1/1/2011
• Rapid in vivo quantification of oxygen concentration in blood flow with a fluorine nanoparticle reporter and a novel blood enhanced saturation recovery (BESR) sequence.
  Hu L, Chen J, Caruthers SD, Lanza GM, Wickline SA, Proc Intl Soc Mag Reson Med, 1/1/2011
• Ultra-short echo time 19F/1H imaging of gadolinium-free perfluoro-carbon nanoparticles: A robust method for in vivo angiogenesis imaging.
  Keupp J, Schmieder AH, Williams TA, Allen JS, Wickline SA, Lanza GM, Caruthers SD, Proc Intl Soc Mag Reson Med, 1/1/2011
• Copper nanoparticles for T1-weighted MR molecular imaging.
  Caruthers SD, Pan D, Senpan A, Schmieder AH, Gaffney PJ, Wickline SA, Lanza GM, Proc Intl Soc Mag Reson Med, 1/1/2011
• Ultra-short echo time balanced SSFP for highly sensitive detection and quantification of multi-resonant 19F imaging agents for targeted molecular MRI.
  Keupp J, Wickline SA, Lanza GM, Caruthers SD, Proc Intl Soc Mag Reson Med, 1/1/2011
• Fluorine magnetic resonance assessment of siRNA delivery to endothelial cells via perfluorocarbon nanoparticles.
  Myerson JW, Kaneda MM, Lanza GM, Wickline SA, FASEB J, 1/1/2010
• An application of smoothing splines for molecular imaging of tumors using an improved calculation of a limiting form of Renyi entropy.
  Hughes MS, marsh JN, Wallace KD, Lanza GM, Wickline SA, McCarty JE, Wickerhauser MV, Maurizi BN, IEEE Ultrasonics Symp, 1/1/2010
• Application of a limiting form of Renyi entropy for molecular imaging of tumors using a clinically relevant protocol.
  Marsh JN, Wallace KD, Lanza GM, Wickline SA, Hughes MS, McCarthy JE, Wickerhauser MV, IEEE Ultrasonics Symp, 1/1/2010
• In vivo 3D 19F fast spectroscopic imaging (F-UTSI) of angiogenesis on Vx2 tumors in rabbits using targeted perfluorocarbon emulsions.
  Lamerichs RM, Yildirim M, Nederveen AJ, Stoker J, Lanza GM, Wickline SA, Caruthers SD, Proc Intl Soc Mag Reson, 1/1/2010
• Hadamard-type pulse-phase encoding for imaging of multi-resonant fluorine-19 nanoparticles in targeted molecular MRI.
  Keupp J, Wickline SA, Lanza GM, Caruthers SD, Proc Intl Soc Mag Reson, 1/1/2010
• Optimization of 19F MR quantification of administrated PFC nanoparticle in vivo: Mathematical simulation and experimental validation.
  Hu L, Zhang L, Chen J, Lanza GM, Wickline SA, Proc Intl Soc Mag Reson Med, 1/1/2010
• Improving T1-weighted “hot spot” imaging with colloidal iron oxide nanoparticles.
  Caruthers SD, Senpan A, Pan D, Hu G, Wickline SA, Lanza GM, Proc Intl Soc Mag Reson, 1/1/2010
• Target-binding of perfluoro-carbon nanoparticles alters optimal imaging parameters using 19F molecular MRI: A study using fast in vitro screening and in vivo tumor mod...
  Keupp J, Wickline SA, Lanza GM, Caruthers SD, Proc Intl Soc Mag Reson, 1/1/2010
• Quantitative molecular imaging of atherosclerotic endothelial dysfunction with perfluorocarbon (19F) nanoparticle magnetic resonance imaging and spectroscopy.
  Zhang L, Zhang H, Bibee K, Allen S, Chen J, Lanza GM, Wickline SA, Proc Intl Soc Mag Reson Med, 1/1/2010
• Join now to see all

Lectures

• Invited Speaker, “Development of Sn-2 lipase labile prodrugs for targeted Nanotherapy" 
  Copenhagen, Denmark - 8/1/2014
• Invited Speaker, “Diagnosis of ventricular assist device (LVAD) thrombosis using fibrin-specific 99mTc imaging agent” 
  St. Louis, MO - 6/1/2014
• Invited Speaker, “Targeted nanoparticles for imaging dynamic processes” 
  Chicago, IL - 5/1/2014
• Invited Speaker, “Imaging insights in atherosclerosis” 
  New York, NY - 5/1/2014
• Invited Speaker, American Society of Nanomedicine 
  Rockville, MD - 3/1/2014
• Invited Speaker, Houston Methodist Research Institute 
  Houston, TX - 1/1/2014
• Invited Speaker, “Characterization of Early Neovascular Response to Acute Lung Ischemia using Simultaneous 19F/1H MR Molecular Imaging” 
  CMR, Beijing, China - 11/1/2013
• Invited Speaker, “Approaching Unmet Medical Needs with Integrated Imaging and Therapy Technologies” 
  Yale University, New Haven, CT - 10/1/2013
• “Emerging Technological Approaches to Cardiovascular and Pulmonary Disease” 
  Manhattan, NY - 10/1/2013
• Invited Speaker, “Advanced Nanotechnologies Addressing Intractable Medical Issues” 
  University of Pennsylvania - 10/1/2013
• Invited Speaker, 2013 Cancer Nanotechnology Gordon Research Conference 
  Boston, MA - 7/1/2013
• “Nanocardiology – Cardiovascular Application” 
  London Excel - 6/1/2013
• “Therapeutic Nanotechnology” 
  Washington, DC - 4/1/2013
• “Nanotheranostics for Cardiovascular Disease and Cancer” 
  Boston, MA - 11/1/2012
• Invited Speaker, SRRSH 7th International Academic Week 
  Hangzhou, China - 10/1/2012
• “Nanomedicine Drug Delivery and Imaging Technologies from CTRAIN” 
  Hyattsville, MD - 9/1/2012
• Invited Speaker, 5th Image Guided Therapy Workshop 
  Boston, MA - 9/1/2012
• “Development of MR Theranostic Agents for Angiogenesis” 
  New Mexico - 8/1/2012
• “Development of MRI Theranostic Agents for Angiogenesis” 
  Harbin, China - 7/1/2012
• “Translational Preclinical Studies to First in Man” 
  Invited Speaker - 6/1/2012
• Invited Moderator “Development and Evaluation of Targeted Imaging Probes-Part II” 
  Bethesda, MD - 4/1/2012
• Speaker “Imaging Angiogenesis and Arteriogenesis, “Multi-Spectral CT of the Vasculature” 
  Bethesda, MD - 4/1/2012
• Session Chair, Society for Endocrinology BES 2012 
  Harrogate, UK - 3/1/2012
• “The Perfect Individual Image” 
  Austria - 1/1/2012
• BiopSys Expert Advisor, BiopSys All Network Meeting 
  Toronto, Canada - 1/1/2012
• Join now to see all

Other

• Universal anchor peptide for nanoparticles. 
  Wickline SA, Pan H, Soman NR, Lanza GM, Schlesinger PH, Washington University, US Patent No. 8,617,516
  12/31/2013
• Applying renyi entropy to detect changes in scattering architecture. 
  Hughes MS, McCarthy J, Lanza G, Wickerhauser MV, Wickline S, Washington University, US Patent No. 8,500,644
  8/6/2013
• Nanoparticle delivery systems for membrane-integrating peptides. 
  Schlessinger P, Soman N, Lanza G, Wickline SA, Washington University, US Patent No. 8,496,945
  7/30/2013
• Targeted MR imaging agents. 
  Lanza, GM, Wickline; Samuel A. (St. Louis, MO), Kiefer; Garry E. (Richardson, TX), Athey; Phillip S, US Patent No. 8,003,078
  8/23/2011
• Nanoparticle delivery systems comprising a hydrophobic core and a lipid/surfactant layer comprising a membrane-lytic peptide. 
  Schlesinger P, Soman N, Lanza G, Wickline SA, Washington University, US Patent No. 7,943,168
  5/17/2011
• Targeted atherosclerosis treatment. 
  Lanza GM, Wickline, SA, Barnes- Jewish Hospital, US Patent No. 7,803,374
  9/28/2010
• Chelating agents with lipophilic carriers. 
  Lanza GM, Wickline SA, Athey PS, Gulyas G, Kiefer GE, Barnes-Jewish Hospital & The Dow Chemical Corporation. US Patent No. 7,279,150
  10/9/2007
• Integrin targeted imaging agents. 
  Lanza GM, Wickline SA, Harris T, Barnes-Jewish Hospital. US Patent No. 7,255,875
  8/14/2007
• Blood clot-targeted nanoparticles. 
  Lanza GM, Wickline SA, Barnes-Jewish Hospital. US Patent No. 7,220,401
  5/22/2007
• Methods for targeted drug delivery. 
  Lanza GM, Wickline SA, Barnes-Jewish Hospital. US Patent No. 7,186,399
  3/6/2007
• Enhanced ultrasound detection with temperature-dependent contrast agents. 
  Lanza GM, Hall CS, Wickline SA, Barnes-Jewish Hospital. US Patent No. 7,179,449.
  2/20/2007
• Paramagnetic particles that provide improved relaxivity. 
  Lanza GM, Wickline SA, US Patent No. 6,869,591
  3/22/2005
• Site-specific binding system, imaging compositions and methods. 
  Lanza GM, Wickline SA, Barnes-Jewish Hospital. US Patent No. 6,821,506
  11/23/2004
• Ligand-targeted emulsions carrying bioactive agents. 
  Lanza GM, Wickline SA, Barnes-Jewish Hospital. US Patent No. 6,676,963
  1/13/2004
• Site specific binding system, imaging compositions and methods. 
  Lanza GM, Wickline SA, Barnes-Jewish Hospital. US Pat No. 5,989,520
  11/23/1999
• Site specific binding system, nuclear imaging compositions and methods. 
  Lanza GM, Wickline SA, Barnes-Jewish Hospital. US Pat No. 5,958,371
  9/28/1999
• Method of MRI using avidin-biotin conjugated emulsions as a site specific binding system. 
  Lanza GM, Wickline SA, Barnes-Jewish Hospital, US Pat No. 5,780,010
  7/14/1998
• Avidin-Biotin conjugated emulsions as a site specific binding system. 
  Lanza GM, Wickline SA, Barnes-Jewish Hospital, US Pat. No. 5,690,907
  11/25/1997
• Acoustically reflective liposomes and methods to make and use the same. 
  Lanza GM, Alkan MH, Klegerman ME, Vonesh MJ, McPherson DD, Northwestern University, US Pat. No: 5,612,057
  3/18/1997
• Composition and method for improving feed utilization or tissue production in animals. 
  DeGeeter M J, Lanza GM, Vineyard BD, Monsanto Company, US Pat. No. 4,618,604
  10/21/1986
• Method for improved bovine milk production. 
  DeGeeter M J, Lanza GM, Monsanto Company, EEC Pat No. EP00085036A1
  8/3/1983
• Join now to see all